Fig. 1From: Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseasessFGL2 levels in patients with HBV-related liver diseases and in healthy controls. sFGL2 levels were measured in study subjects and compared between subgroups. HC, healthy controls; AHB, acute hepatitis B; CHB, chronic hepatitis B; LC, patients with liver cirrhosis; HCC, patients with hepatocellular carcinoma; LC + HCC, patients with both liver cirrhosis and hepatocellular carcinoma. (*): P < 0.0001 for comparison with other groups. Box plots illustrate medians with inter-quartile range. P values were calculated by Mann-Whitney-Wilcoxon testBack to article page